Table of contents
31 August 2019
Notices
31 August 2019
CREBZF as a Key Regulator of STAT3 Pathway in the Control of Liver Regeneration in Mice
Zhimin Hu, Yamei Han, Yuxiao Liu, Zehua Zhao, Fengguang Ma, Aoyuan Cui, Feifei Zhang, Zhengshuai Liu, Yaqian Xue, Jinyun Bai, Haifu Wu, Hua Bian, Y. Eugene Chin, Ying Yu, Zhuoxian Meng, Hua Wang, Yong Liu, Jiangao Fan, Xin Gao, Yan Chen, Yu Li – 30 August 2019
Interplay of Liver–Heart Inflammatory Axis and Cannabinoid 2 Receptor Signaling in an Experimental Model of Hepatic Cardiomyopathy
Csaba Matyas, Katalin Erdelyi, Eszter Trojnar, Suxian Zhao, Zoltan V. Varga, Janos Paloczi, Partha Mukhopadhyay, Balazs T. Nemeth, György Haskó, Resat Cinar, Robim M. Rodrigues, Yeni Ait Ahmed, Bin Gao, Pal Pacher – 30 August 2019
Mesencephalic Astrocyte‐Derived Neurotrophic Factor Inhibits Liver Cancer Through Small Ubiquitin‐Related Modifier (SUMO)ylation‐Related Suppression of NF‐κB/Snail Signaling Pathway and Epithelial‐Mesenchymal Transition
Jun Liu, Zhengsheng Wu, Dan Han, Chuansheng Wei, Yanyan Liang, Tongcui Jiang, Lu Chen, Manqi Sha, Yajie Cao, Fan Huang, Xiaoping Geng, Jishuang Yu, Yujun Shen, Hua Wang, Lijie Feng, Dong Wang, Shengyun Fang, Siying Wang, Yuxian Shen – 30 August 2019
Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome
Joshua M. Adams, Kari A. Huppert, Eumenia C. Castro, Mario F. Lopez, Nima Niknejad, Sanjay Subramanian, Neda Zarrin‐Khameh, Milton J. Finegold, Stacey S. Huppert, Hamed Jafar‐Nejad – 30 August 2019
CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and Activation
Tin‐Lok Wong, Kai‐Yu Ng, Kel Vin Tan, Lok‐Hei Chan, Lei Zhou, Noélia Che, Ruby L.C. Hoo, Terence K. Lee, Stéphane Richard, Chung‐Mau Lo, Kwan Man, Pek‐Lan Khong, Stephanie Ma – 30 August 2019
hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis
Jing Xiong, Tongyu Liu, Lin Mi, Henry Kuang, Xuelian Xiong, Zhimin Chen, Siming Li, Jiandie D. Lin – 30 August 2019
Management of Patients With Erythropoietic Protoporphyria–Related Progressive Liver Disease
Zaid S. Ardalan, Sujievvan Chandran, Abhinav Vasudevan, Peter W. Angus, Andrew Grigg, Simon He, Graeme A. Macdonald, Simone I. Strasser, Courtney J. Tate, Glen A. Kennedy, Adam G. Testro, Paul J. Gow – 30 August 2019 – Erythropoietic protoporphyria (EPP) is an inherited metabolic disorder of heme synthesis resulting from overproduction of protoporphyrin IX (PPIX), which can lead to progressive liver disease characterized by recurrent EPP crises and end‐stage liver disease.
Master of Disguise: Hepatitis Delta Virus Packaging and Spread Facilitated by Diverse Viral Envelope Proteins
Stephanie Maya, Alexander Ploss – 29 August 2019